Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2020-06-05 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 1% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by Cellumed. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2020-06-05 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from Cellumed regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It details the issuance of new shares, the purpose of the capital raise (operating funds and debt repayment), and the list of third-party allottees. This is a formal regulatory filing concerning capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2020-06-04 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제23회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) regarding the acquisition of convertible bonds before maturity by the company Cellumed. It details the specific bond series (23rd), the acquisition amount, the reason (default/acceleration of maturity), and the method of disposal (cancellation). This falls under capital structure changes and financing updates, specifically related to debt instruments.
2020-06-03 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제22회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing regarding the acquisition of convertible bonds before maturity (a debt-related capital event). It details the specific bond series (22nd issue), the acquisition amount, the reason for acquisition (default/acceleration), and the method of cancellation. This falls under capital structure and financing updates, specifically related to debt instruments.
2020-06-03 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제21회차)
Capital/Financing Update Classification · 1% confidence The document is a formal regulatory filing regarding the 'acquisition of convertible bonds before maturity' (전환사채 발행후 만기전 사채 취득). This type of disclosure relates to the company's capital structure and debt management. Since it specifically details the repurchase/acquisition of its own debt instruments (convertible bonds), it falls under the category of capital and financing updates.
2020-06-03 Korean
단기차입금증가결정
Capital/Financing Update Classification · 1% confidence The document is a formal announcement regarding a decision to increase short-term borrowings (단기차입금증가결정) by the company Cellumed. It details the amount, purpose (repayment of convertible bonds), and board approval date. This type of disclosure regarding financing activities and capital structure changes falls under the 'Capital/Financing Update' category.
2020-06-01 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.